Grigorian L G, Chervinskaia T A
Klin Med (Mosk). 1993;71(5):24-7.
The study revealed the relation of bronchial asthma (bacterial variant) clinical pattern to plasma levels of PGF2 alpha, 6-keto-PGF1 alpha and TxB2. In remission of the disease the above indices are lower. Severe asthma remission is characterized by higher levels of 6-keto-PGF1 alpha and TxB2 than moderate asthma one, demonstrates a tendency to growing PGF2 alpha levels. A rise in PGF2 alpha and TxB2 in manifest asthma points to their participation in bronchospasm formation suggesting an active role of these bronchoconstrictors in asthma pathogenesis. Higher levels of 6-keto-PGF1 alpha are of a compensary nature in the pathogenesis of PGF2 alpha and TxB2 bronchoconstrictory action, and of damaging nature contributing to the formation of bronchial mucosa edema and bronchial gland hypersecretion.
该研究揭示了支气管哮喘(细菌变异型)临床模式与血浆中前列腺素F2α、6-酮-前列腺素F1α和血栓素B2水平之间的关系。在疾病缓解期,上述指标较低。重度哮喘缓解期的特点是6-酮-前列腺素F1α和血栓素B2水平高于中度哮喘缓解期,且前列腺素F2α水平有升高趋势。显性哮喘中前列腺素F2α和血栓素B2的升高表明它们参与了支气管痉挛的形成,提示这些支气管收缩剂在哮喘发病机制中起积极作用。较高水平的6-酮-前列腺素F1α在前列腺素F2α和血栓素B2支气管收缩作用的发病机制中具有补偿性质,且具有损害性质,有助于支气管黏膜水肿和支气管腺体分泌过多的形成。